Why the study?
Does intraoperative radiofrequency ablation prevent arrhythmia recurrence in adult patients with congenital heart disease and supraventricular arrhythmias undergoing concomitant cardiac surgery?
Does intraoperative radiofrequency ablation prevent arrhythmia recurrence in adult patients with congenital heart disease and supraventricular arrhythmias undergoing concomitant cardiac surgery?
Intraoperative radiofrequency ablation during concomitant cardiac surgery in adults with congenital heart disease is effective, achieving 75% freedom from arrhythmia recurrence at 6 years.
Answers are grounded in this paper and cite their sources.
May support concomitant ablation in adult congenital heart disease surgery; leaves open randomized confirmation of efficacy and predictors.
AIMS: Supraventricular arrhythmias are a major cause of morbidity and mortality in adult patients with congenital heart disease (CHD). Intraoperative ablation offers an alternative for patients who failed ablation procedures or are requiring concomitant surgical intervention. We present our long-term results with the surgical treatment of arrhythmias in adults with CHD (ACHD) undergoing elective cardiac surgery and the clinical predictors for arrhythmia recurrence. METHODS AND RESULTS: Between 2002 and 2013, 80 consecutive patients with CHD, mean age of 39 years, underwent intraoperative ablation with monopolar irrigated radiofrequency during cardiac surgery procedures. Significant clinical predictors of arrhythmia recurrence were determined by univariate analysis. We performed 47 right-sided Maze procedures, and 33 Cox-Maze III procedures. In 75 survivors, the ablation was effective immediately. Over an average follow-up period of 72 months (12-155 months), arrhythmias recurred in nine (20%) patients after right-sided Maze, and in six (19%) patients after Cox-Maze III. Eleven patients were controlled with medical therapy, three underwent catheter ablation of the arrhythmia, and one required a permanent pacemaker. Preoperative arrhythmia length ≥3 years (P ≤ 0.001), tetralogy of Fallot (P ≤ 0.006), and preoperative atrial fibrillation (P ≤ 0.016) were associated with recurrence arrhythmia. Conversely, NYHA class <3 (P ≤ 0.047) was associated with a lower risk of recurrence. CONCLUSION: Surgical treatment of unresponsive supraventricular arrhythmia during concomitant cardiac surgery in ACHD is a safe and effective procedure. Freedom from arrhythmias recurrence is 75% after 6 years of follow-up. Long-term recurrence of arrhythmia in these patients seems to be strongly correlated to preoperative arrhythmia duration.
No takes yet. Share an insight, caveat, or question.
Giamberti et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: